F16, a Mitochondriotoxic Compound, Triggers Apoptosis or Necrosis Depending on the Genetic Background of the Target Carcinoma Cell

Cancer Research

Volumn 64, Issue 1, 2004, Pages 329-336

  Fantin, Valeria R ^a   Leder, Philip ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE INHIBITOR; ETOPOSIDE; F 16; PROTEIN BCL 2; STAUROSPORINE; THAPSIGARGIN; TIRON; UNCLASSIFIED DRUG; ZVAD FMK;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; DNA MODIFICATION; GENE MUTATION; GENE OVEREXPRESSION; MITOCHONDRION; MOLECULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; TARGET CELL;

APOPTOSIS; CARCINOMA; CASPASES; CELL DEATH; CELL DIVISION; CELL LINE, TUMOR; CYSTEINE PROTEINASE INHIBITORS; FLOW CYTOMETRY; HOMEOSTASIS; HUMANS; INDOLES; MITOCHONDRIA; NECROSIS; OXIDATION-REDUCTION; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRIDINIUM COMPOUNDS;

EID: 1642494810     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-0899     Document Type: Article

References (45)

1. Fantin, V. R., Berardi, M. J., Scorrano, L., Korsmeyer, S. J., and Leder, P. A novel mitochondriotoxic small molecule that selectively inhibits tumor cell growth. Cancer Cell, 2: 29-42, 2002.
2. Chen, L. B. Mitochondrial membrane potential in living cells. Annu. Rev. Cell Biol., 4: 155-181, 1988.
3. Modica-Napolitano, J. S., and Aprille, J. R. Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells. Adv. Drug Delivery Rev., 49: 63-70, 2001.
4. Bernardi, P., Scorrano, L., Colonna, R., Petronilli, V., and Di Lisa, F. Mitochondria and cell death: mechanistic aspects and methodological issues. Eur. J. Biochem., 264: 687-701, 1999.
5. Ravagnan, L., Roumier, T., and Kroemer, G. Mitochondria, the killer organelles and their weapons. J. Cell. Physiol., 192: 131-137, 2002.
6. Cory, S., and Adams, J. M. The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer, 2: 647-656, 2002.
7. Kolenko, V., Uzzo, R. G., Bukowski, R., Bander, N. H., Novick, A. C., Hsi, E. D., and Finke, J. H. Dead or dying: necrosis versus apoptosis in caspase-deficient human renal cell carcinoma. Cancer Res., 59: 2838-2842, 1999.
8. Vogelstein, B., Lane, D., and Levine, A. J. Surfing the p53 network. Nature (Lond.), 408: 307-310, 2000.
9. Costantini, P., Jacotot, E., Decaudin, D., and Kroemer, G. Mitochondrion as a novel target of anticancer chemotherapy. J. Natl. Cancer Inst. (Bethesda), 92: 1042-1053, 2000.
10. Degterev, A., Boyce, M., and Yuan, J. The channel of death. J. Cell Biol., 155: 695-698, 2001.
11. Joza, N., Kroemer, G., and Penninger, J. M. Genetic analysis of the mammalian cell death machinery. Trends Genet., 18: 142-149, 2002.
12. Newmeyer, D. D., and Ferguson-Miller, S. Mitochondria: releasing power for life and unleashing the machineries of death. Cell, 112: 481-490, 2003.
13. Wei, M. C., Zong, W. X., Cheng, E. H., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., Roth, K. A., MacGregor, G. R., Thompson, C. B., and Korsmeyer, S. J. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science (Wash. DC), 292: 727-730, 2001.
14. Kitada, S., Pedersen, I. M., Schimmer, A. D., and Reed, J. C. Dysregulation of apoptosis genes in hematopoietic malignancies. Oncogene, 21: 3459-3474, 2002.
15. Reed, J. C. Dysregulation of apoptosis in cancer. J. Clin. Oncol., 17: 2941-2953, 1999.
16. Gross, A., McDonnell, J. M., and Korsmeyer, S. J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev., 13: 1899-1911, 1999.
17. Johnstone, R. W., Ruefli, A. A., and Lowe, S. W. Apoptosis: a link between cancer genetics and chemotherapy. Cell, 108: 153-164, 2002.
18. Miyashita, T., and Reed, J. C. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood, 81: 151-157, 1993.
19. Konopleva, M., Zhao, S., Hu, W., Jiang, S., Snell, V., Weidner, D., Jackson, C. E., Zhang, X., Champlin, R., Estey, E., Reed, J. C., and Andreeff, M. The anti-apoptotic genes Bcl-X(L) and Bcl-2 are over-expressed and contribute to chemoresistance of non-proliferating leukaemic CD34+ cells. Br. J. Haematol., 118: 521-534, 2002.
20. Scherr, D. S., Vaughan, E. D., Jr., Wei, J., Chung, M., Felsen, D., Allbright, R., and Knudsen, B. S. BCL-2 and p53 expression in clinically localized prostate cancer predicts response to external beam radiotherapy. J. Urol., 162: 12-16; discussion 16-17, 1999.
21. Marzo, I., Brenner, C., and Kroemer, G. The central role of the mitochondrial megachannel in apoptosis: evidence obtained with intact cells, isolated mitochondria, and purified protein complexes. Biomed. Pharmacother., 52: 248-251, 1998.
22. Hockenbery, D. M., Oltvai, Z. N., Yin, X. M., Milliman, C. L., and Korsmeyer, S. J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell, 75: 241-251, 1993.
23. Yang, J., Liu, X., Bhalla, K., Kim, C. N., lbrado, A. M., Cai, J., Peng, T. I., Jones, D. P., and Wang, X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science (Wash. DC), 275: 1129-1132, 1997.
24. Kluck, R. M., Bossy-Wetzel, E., Green, D. R., and Newmeyer, D. D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science (Wash. DC), 275: 1132-1136, 1997.
25. Weinstein, E. J., Grimm, S., and Leder, P. The oncogene heregulin induces apoptosis in breast epithelial cells and tumors. Oncogene, 17: 2107-2113, 1998.
26. Thomas, D. A., Scorrano, L., Putcha, G. V., Korsmeyer, S. J., and Ley, T. J. Granzyme B can cause mitochondrial depolarization and cell death in the absence of BID, BAX, and BAK. Proc. Nad. Acad. Sci. USA, 98: 14985-14990, 2001.
27. Thongphasuk, J., Oberley, L. W., and Oberley, T. D. Induction of superoxide dismutase and cytotoxicity by manganese in human breast cancer cells. Arch. Biochem. Biophys., 365: 317-327, 1999.
28. Leist, M., Single, B., Castoldi, A. F., Kuhnle, S., and Nicotera, P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med., 185: 1481-1486, 1997.
29. Costantini, P., Petronilli, V., Colonna, R., and Bernardi, P. On the effects of paraquat on isolated mitochondria: evidence that paraquat causes opening of the cyclosporin A-sensitive permeability transition pore synergistically with nitric oxide. Toxicology, 99: 77-88, 1995.
30. Decaudin, D., Geley, S., Hirsch, T., Castedo, M., Marchetti, P., Macho, A., Kofler, R., and Kroemer, G. Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res., 57: 62-67, 1997.
31. Simonian, P. L., Grillot, D. A., and Nunez, G. Bcl-2 and Bcl-XL can differentially block chemotherapy-induced cell death. Blood, 90: 1208-1216, 1997.
32. Kroemer, G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med., 3: 614-620, 1997.
33. Summerhayes, I. C., Lampidis, T. J., Bernal, S. D., Nadakavukaren, J. J., Nadakavukaren, K. K., Shepherd, E. L., and Chen, L. B. Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells. Proc. Natl. Acad. Sci. USA, 79: 5292-5296, 1982.
34. Raha, S., and Robinson, B. H. Mitochondria, oxygen free radicals, and apoptosis. Am. J. Med. Genet., 106: 62-70, 2001.
35. Zhu, L., Ling, S., Yu, X. D., Venkatesh, L. K., Subramanian, T., Chinnadurai, G., and Kuo, T. H. Modulation of mitochondrial Ca(2+) homeostasis by Bcl-2. J. Biol. Chem., 274: 33267-33273, 1999.
36. Eguchi, Y., Shimizu, S., and Tsujimoto, Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res., 57: 1835-1840, 1997.
37. Meilhac, O., Escargueil-Blanc, I., Thiers, J. C., Salvayre, R., and Negre-Salvayre, A. Bcl-2 alters the balance between apoptosis and necrosis, but does not prevent cell death induced by oxidized low density lipoproteins. FASEB J., 13: 485-494, 1999.
38. Kroemer, G., Dallaporta, B., and Resche-Rigon, M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol., 60: 619-642, 1998.
39. Green, D., and Kroemer, G. The central executioners of apoptosis: caspases or mitochondria?. Trends Cell Biol., 8: 267-271, 1998.
40. Hahn, W. C., and Weinberg, R. A. Modelling the molecular circuitry of cancer. Nat. Rev. Cancer, 2: 331-341, 2002.
41. Kiaris, H., and Schally, A. V. Apoptosis versus necrosis: which should be the aim of cancer therapy?. Proc. Soc. Exp. Biol. Med., 221: 87-88, 1999.
42. Dewey, W. C., Ling, C. C., and Meyn, R. E. Radiation-induced apoptosis: relevance to radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 33: 781-796, 1995.
43. Dartsch, D. C., Schaefer, A., Boldt, S., Kolch, W., and Marquardt, H. Comparison of anthracycline-induced death of human leukemia cells: programmed cell death versus necrosis. Apoptosis, 7: 537-548, 2002.
44. Reiter, I., Krammer, B., and Schwamberger, G. Cutting edge: differential effect of apoptotic versus necrotic tumor cells on macrophage antitumor activities. J. Immunol., 163: 1730-1732, 1999.
45. Proskuryakov, S. Y., Konoplyannikov, A. G., and Gabai, V. L. Necrosis: a specific form of programmed cell death? Exp. Cell Res., 283: 1-16, 2003.